» Articles » PMID: 20549820

Telomere Length and Genetic Analyses in Population-based Studies of Endometrial Cancer Risk

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2010 Jun 16
PMID 20549820
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Telomeres are protective structures at the ends of linear chromosomes, regulated by a host of associated proteins. When telomeres become dysfunctional, genomic instability ensues. The vast majority of cells undergo apoptosis, although a rare cell may survive and become tumorigenic.

Methods: The authors used conditional logistic regression to examine relative telomere length in peripheral blood leukocytes, genetic variants at telomere maintenance gene loci (TERT, TNKS2, POT1, TERF1, TERF2), and endometrial cancer risk in case-control studies nested within the Nurses' Health Study and the Women's Health Study.

Results: Relative telomere length was significantly inversely correlated with body mass index and weight gain since age 18 years. The authors did not observe a relationship between relative telomere length and endometrial cancer risk. Women in the shortest quartile had a multivariate-adjusted odds ratio (OR) of 1.20 (95% confidence interval [95% CI], 0.73-1.96; P for trend = .37) compared with women in the longest quartile. The authors found an elevation in endometrial cancer risk among women carrying at least 1 minor allele of RS2736122 (TERT; OR, 1.18; 95% CI, 1.01-1.38) or RS12412538 (TNKS2; OR, 1.16; 95% CI, 1.00-1.34).

Conclusions: Relative telomere length was not associated with endometrial cancer risk. Other aspects of telomere maintenance remain to be explored.

Citing Articles

Association of telomerase reverse transcriptase gene rs10069690 variant with cancer risk: an updated meta-analysis.

Zhou C, Yang Y, Shen L, Wang L, Zhang J, Wu X BMC Cancer. 2024; 24(1):1059.

PMID: 39192222 PMC: 11350973. DOI: 10.1186/s12885-024-12833-2.


Review of Mendelian Randomization Studies on Endometrial Cancer.

Guo J, Wu Q, Liu F, Gao C, Gong T, Li G Front Endocrinol (Lausanne). 2022; 13:783150.

PMID: 35615721 PMC: 9124776. DOI: 10.3389/fendo.2022.783150.


Endometrial cancer: a genetic point of view.

Bianco B, Barbosa C, Trevisan C, Lagana A, Montagna E Transl Cancer Res. 2022; 9(12):7706-7715.

PMID: 35117373 PMC: 8797944. DOI: 10.21037/tcr-20-2334.


Telomeres and Telomere Length: A General Overview.

Srinivas N, Rachakonda S, Kumar R Cancers (Basel). 2020; 12(3).

PMID: 32121056 PMC: 7139734. DOI: 10.3390/cancers12030558.


TERT rs10069690 polymorphism and cancers risk: A meta-analysis.

He G, Song T, Zhang Y, Chen X, Xiong W, Chen H Mol Genet Genomic Med. 2019; 7(10):e00903.

PMID: 31454181 PMC: 6785442. DOI: 10.1002/mgg3.903.


References
1.
Petersen S, Saretzki G, von Zglinicki T . Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Exp Cell Res. 1998; 239(1):152-60. DOI: 10.1006/excr.1997.3893. View

2.
Aviv A, Chen W, Gardner J, Kimura M, Brimacombe M, Cao X . Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa Heart Study. Am J Epidemiol. 2008; 169(3):323-9. PMC: 2638944. DOI: 10.1093/aje/kwn338. View

3.
Stewart S, Weinberg R . Telomeres: cancer to human aging. Annu Rev Cell Dev Biol. 2006; 22:531-57. DOI: 10.1146/annurev.cellbio.22.010305.104518. View

4.
Shen J, Gammon M, Terry M, Wang Q, Bradshaw P, Teitelbaum S . Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer. 2008; 124(7):1637-43. PMC: 2727686. DOI: 10.1002/ijc.24105. View

5.
Butler M, Tilburt J, DeVries A, Muralidhar B, Aue G, Hedges L . Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages. Cancer Genet Cytogenet. 1998; 105(2):138-44. PMC: 6765222. DOI: 10.1016/s0165-4608(98)00029-6. View